Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Lipodystrophies
ADR ID BADD_A02556
ADR Hierarchy
23      Skin and subcutaneous tissue disorders
23.07      Skin and subcutaneous tissue disorders NEC
23.07.01      Lipodystrophies
Description A collection of heterogenous conditions resulting from defective LIPID METABOLISM and characterized by ADIPOSE TISSUE atrophy. Often there is redistribution of body fat resulting in peripheral fat wasting and central adiposity. They include generalized, localized, congenital, and acquired lipodystrophy. [MeSH]
MedDRA Code 10024606
MeSH ID D008060
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Lipodystrophy | Lipodystrophies
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00008Abacavir--
BADD_D00066Alendronic acid0.000044%
BADD_D00086Alprostadil0.001148%
BADD_D00136Amprenavir--
BADD_D00174Asfotase alfa--
BADD_D00176Atazanavir0.003608%
BADD_D00306Budesonide--
BADD_D00490Clobetasol propionate0.001867%
BADD_D00586Darunavir0.001356%
BADD_D00603Delavirdine--
BADD_D00609Deoxycholic acid0.000603%
BADD_D00661Didanosine--
BADD_D00704Dolutegravir sodium--
BADD_D00749Efavirenz0.024590%
BADD_D00766Emtricitabine0.001866%
BADD_D00857Etravirine--
BADD_D00898Finasteride0.000180%
BADD_D00917Fludrocortisone--
BADD_D00918Fludrocortisone acetate--
BADD_D00961Fosamprenavir calcium--
BADD_D01020Glatiramer--
BADD_D01021Glatiramer acetate--
BADD_D01150Indinavir--
BADD_D01159Insulin (human)--
BADD_D01160Insulin aspart--
BADD_D01161Insulin degludec--
BADD_D01162Insulin detemir--
BADD_D01163Insulin glargine--
BADD_D01164Insulin glulisine--
BADD_D01165Insulin lispro--
The 1th Page    1 2    Next   Last    Total 2 Pages